BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2008
View Archived Issues
LY-450139 safe and well tolerated in Japanese subjects
Read More
Beneficial activity of CHF-5074 seen in mouse, guinea pig models of Alzheimer's disease
Read More
Imaging study reveals effects of GSK-189254 on cognition
Read More
Antitumor activity seen with PF-00299804 in several human xenograft models
Read More
NeuroPharma describes glycogen synthase kinase-3 inhibitor derived from marine organism
Read More
Meda and Valeant form joint ventures in Australia, Canada and Mexico
Read More
Celgene terminates satraplatin agreement with GPC Biotech
Read More
Mipomersen enters second phase III trial
Read More
Bayer acquires preclinical oncology program from Nycomed
Read More
Once-daily administration of RDEA-806 is safe and active against HIV in a phase II study
Read More
FDA grants orphan drug designation to SuperGen's MP-470 in glioblastoma multiforme
Read More
Cleveland receives notice of allowance from FDA to initiate phase I trial of Protectan CBLB-502
Read More
OrthoLogic reports positive results from preclinical study of Chrysalin in acute heart disease
Read More
Sonus signs exclusive in-licensing agreement with Bayer Healthcare for caspase activators
Read More
InNexus initiates primate study of DXL-625 antibody and adds DXLr-120 to pipeline
Read More
University of Texas Southwestern Medical Center initiates clinical trial of DOR's RiVax
Read More
Generex initiates enrollment in phase I clinical trial of AE-37 cancer vaccine
Read More
BioSante reacquires Elestrin from Nycomed
Read More
Oramed reports positive results from phase IIa clinical trial of ORMD-0801 in type 2 diabetes
Read More
Novel compounds for the treatment of cardiovascular disorders described in recent patents
Read More
HIV vaccine Vacc-4x enters phase IIb study
Read More
Patents disclose novel antiplatelet and anticoagulant compounds
Read More
Novel agents potentially useful for the treatment of cancer reported in recent patents
Read More
